إعلان
إعلان

RXST

RXST logo

RxSight, Inc. Common Stock

8.86
USD
برعاية
-0.71
-7.47%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

9.08

+0.22
+2.54%

تقارير أرباح RXST

النسبة الإيجابية المفاجئة

RXST تفوق 16 من 18 آخر التقديرات.

89%

التقرير التالي

بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$28.08M
/
-$0.34
التغير الضمني من Q3 25 (Revenue/ EPS)
-7.44%
/
+41.67%
التغير الضمني من Q4 24 (Revenue/ EPS)
-30.17%
/
+126.67%

RxSight, Inc. Common Stock earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, RXST reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.38 USD, resulting in a 37.87% surprise. Revenue reached 30.34 مليون, compared to an expected 25.78 مليون, with a 17.67% difference. The market reacted with a +3.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 المحللين forecast an EPS of -0.34 USD, with revenue projected to reach 28.08 مليون USD, implying an زيادة of 41.67% EPS, and نقصان of -7.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, RxSight, Inc. Common Stock reported EPS of -$0.24, beating estimates by 37.87%, and revenue of $30.34M, 17.67% above expectations.
The stock price moved up 3.24%, changed from $8.34 before the earnings release to $8.61 the day after.
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
Based on 13 المحللين, RxSight, Inc. Common Stock is expected to report EPS of -$0.34 and revenue of $28.08M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان